Publication:
Prognostic Value of Angiogenesis and Survivin Expression in Patients with Glioblastoma

Simple item page
dc.contributor.authorTastekin, Ebru
dc.contributor.authorCaloglu, Vuslat Yurut
dc.contributor.authorOz Puyan, Fulya
dc.contributor.authorTokuc, Burcu
dc.contributor.authorCaloglu, Murat
dc.contributor.authorYalta, Tulin Deniz
dc.contributor.authorCan, Nuray
dc.contributor.authorGuler, Beril
dc.contributor.institutionauthorGÜLER, BERIL
dc.date.accessioned2020-10-29T22:17:17Z
dc.date.available2020-10-29T22:17:17Z
dc.date.issued2016-07-01T00:00:00Z
dc.description.abstractAIM: Glioblastoma (GBM) is the most common and the most aggressive primary brain tumor with poor prognosis. We aimed to evaluate the association between immunohistochemical expression of survivin and angiogenic parameters (microvessel density and vascular pattern) in patients who underwent surgery for GBM.
dc.identifier.citationTastekin E., Caloglu V. Y. , Oz Puyan F., Tokuc B., Caloglu M., Yalta T. D. , Can N., Guler B., -Prognostic Value of Angiogenesis and Survivin Expression in Patients with Glioblastoma-, TURKISH NEUROSURGERY, cilt.26, ss.484-490, 2016
dc.identifier.doi10.5137/1019-5149.jtn.16552-15.1
dc.identifier.scopus85016923430
dc.identifier.urihttp://hdl.handle.net/20.500.12645/26519
dc.identifier.wosWOS:000381591600003
dc.titlePrognostic Value of Angiogenesis and Survivin Expression in Patients with Glioblastoma
dc.typeArticle
dspace.entity.typePublication
local.avesis.idaae69994-c6f0-48b5-82dc-cd4794f415ab
local.indexed.atWOS
local.indexed.atScopus
local.publication.isinternational1
relation.isAuthorOfPublicationfee8c5f9-2d88-41e7-8d6d-87789705739a
relation.isAuthorOfPublication.latestForDiscoveryfee8c5f9-2d88-41e7-8d6d-87789705739a

Files

Collections

Diğer Yayınlar